Scroll

Bladder seen under White Light

Bladder seen under Blue Light

Confidence for Bladder Cancer Patients Making cancer visible
This video shows a bladder cancer surgery procedure (Transurethral Resection of Bladder Tumor (TURBT) performed with Blue Light as adjunct to White Light Cystoscopy. With courtesy of Maximillian Burger, Germany
Latest News See more news
  • 07.08.2019
    Photocure ASA: Results for the second quarter and first half of 2019

    Oslo, Norway, 7 August 2019: Photocure ASA (OSE:PHO), today reported a revenue growth of 41% in local currency for the U.S. market in the second quarter of 2019, contributing to Hexvix/Cysview revenues of NOK 52.1 million (Q2 2018: NOK 42.4) and a recurring EBITDA of NOK -2.6 million (NOK 0.7 million). The company continues to receive strong endorsement for the use of Blue Light Cystoscopy (BLC) with Cysview and reiterates the significant revenue growth and profit opportunities in the U.S. market.

    07.08.2019
  • 31.07.2019
    Photocure ASA: Invitation to second quarter and first half year 2019 results presentation and webcast

    Photocure will present its second quarter and first half year report on Wednesday 7 August 2019 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET).

    31.07.2019
  • 30.07.2019
    Photocure to present at European Biotech Investor Day 2019 in New York

    Oslo, Norway, August 1, 2019 - Photocure ASA (OSE: PHO) management is conducting investor meetings in New York (US) on August 1, 2019, in connection with the European Biotech Investor Day, organized by Solebury Trout and sponsored by Goodwin LLC, Deutsche Bank, H.C. Wainwright and Nasdaq.

    30.07.2019
Photocure, The Bladder Cancer Company, delivers transformative solutions to improve the lives of bladder cancer patients